Comments
Loading...
Liquidia Insider Trading Activity | NASDAQ:LQDA | Benzinga
Track the latest Liquidia insider trading activity. Stay informed on recent buys, sells, and market impact for Liquidia stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Liquidia Corp Insiders Doing?
At Liquidia Corp, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of - shares worth -, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On January 29, 2025, Jason Adair, the company's CHIEF BUSINESS OFFICER sold 445 shares for $14.2 each.
- On January 23, 2025, Rajeev Saggar, the company's CHIEF MEDICAL OFFICER sold 2.44K shares for $13 each.
Ownership Statistics for Liquidia Corp
Shares Outstanding
85.299M
Insider Shares Owned
6.536M
Insider Percentage Owned
7.72%
Institutional Shares Held
15.077M
Institutional Percentage Held
17.8%
| Mar 04, 2025 | Russell Schundler | GENERAL COUNSEL | 1.41K | $15.45 | -$14.37K | SELL-OPTIONS | 0.24% | 590.76K | Feb 28 - Mar 03 | View |
| Mar 04, 2025 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 1.28K | $15.45 | -$9.15K | SELL-OPTIONS | 0.59% | 218.15K | Feb 28 - Mar 03 | View |
| Mar 04, 2025 | Michael Kaseta | CFO AND COO | 1.47K | $15.45 | -$13.50K | SELL-OPTIONS | 0.36% | 404.60K | Feb 28 - Mar 03 | View |
| Mar 04, 2025 | Jason Adair | CHIEF BUSINESS OFFICER | 1.11K | $15.45 | -$6.97K | SELL-OPTIONS | 0.61% | 182.25K | Feb 28 - Mar 03 | View |
| Jan 29, 2025 | Jason Adair | CHIEF BUSINESS OFFICER | -445.00 | $14.20 | -$6.32K | SELL | -0.25% | 179.77K | Jan 27 | View |
| Jan 23, 2025 | Rajeev Saggar | CHIEF MEDICAL OFFICER | -2.44K | $13.00 | -$31.79K | SELL | -0.90% | 267.94K | Jan 21 | View |
| Jan 14, 2025 | Russell Schundler | GENERAL COUNSEL | 86.15K | $11.78 | -$193.11K | GRANT | 17.17% | 587.98K | Jan 11 - Jan 14 | View |
| Jan 14, 2025 | Rajeev Saggar | CHIEF MEDICAL OFFICER | 65.53K | $11.78 | -$73.61K | GRANT | 31.99% | 270.39K | Jan 11 - Jan 14 | View |
| Jan 14, 2025 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 61.37K | $11.78 | -$98.50K | GRANT | 39.82% | 215.49K | Jan 11 - Jan 14 | View |
| Jan 14, 2025 | Michael Kaseta | CFO AND COO | 89.43K | $11.78 | -$275.30K | GRANT | 28.63% | 401.75K | Jan 11 - Jan 14 | View |
| Jan 14, 2025 | Jason Adair | CHIEF BUSINESS OFFICER | 60.99K | $11.78 | -$56.65K | SELL-OPTIONS | 51.16% | 180.22K | Jan 11 - Jan 14 | View |
| Jan 14, 2025 | Roger Jeffs | CHIEF EXECUTIVE OFFICER | 206.98K | $11.78 | -$263.20K | GRANT | 8.79% | 2.56M | Jan 11 - Jan 14 | View |
| Dec 03, 2024 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 1.33K | $11.51 | -$6.28K | SELL-OPTIONS | 0.87% | 154.13K | Nov 30 - Dec 02 | View |
| Dec 03, 2024 | Michael Kaseta | CFO AND COO | 1.25K | $11.51 | -$12.56K | SELL-OPTIONS | 0.40% | 312.33K | Nov 30 - Dec 02 | View |
| Dec 03, 2024 | Russell Schundler | GENERAL COUNSEL | 1.28K | $11.51 | -$12.24K | SELL-OPTIONS | 0.26% | 501.83K | Nov 30 - Dec 02 | View |
| Dec 03, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | 1.11K | $11.51 | -$5.24K | SELL-OPTIONS | 0.94% | 119.22K | Nov 30 - Dec 02 | View |
| Oct 29, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | 459.00 | $11.31 | $5.19K | s | 0.39% | 118.11K | Oct 28 | View |
| Oct 22, 2024 | Rajeev Saggar | CHIEF MEDICAL OFFICER | -2.53K | $11.19 | -$28.27K | SELL | -1.22% | 204.86K | Oct 18 | View |
| Oct 15, 2024 | Russell Schundler | GENERAL COUNSEL | -2.58K | $11.11 | -$28.61K | SELL | -0.51% | 500.55K | Oct 14 | View |
| Oct 15, 2024 | Rajeev Saggar | CHIEF MEDICAL OFFICER | -2.26K | $11.11 | -$25.10K | SELL | -1.08% | 207.38K | Oct 14 | View |
| Oct 15, 2024 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | -1.53K | $11.11 | -$16.96K | SELL | -0.99% | 152.80K | Oct 14 | View |
| Oct 15, 2024 | Michael Kaseta | CFO AND COO | -3.89K | $11.11 | -$43.23K | SELL | -1.24% | 311.08K | Oct 14 | View |
| Oct 15, 2024 | Roger Jeffs | CHIEF EXECUTIVE OFFICER | -8.05K | $11.11 | -$89.45K | SELL | -0.34% | 2.35M | Oct 14 | View |
| Oct 15, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | 2.76K | $11.11 | -$12.73K | SELL-OPTIONS | 2.38% | 118.57K | Oct 11 - Oct 14 | View |
| Sep 16, 2024 | Paul B Manning | DIRECTOR | 337.08K | $8.90 | $3.00M | BUY | 9.33% | 3.95M | Sep 12 | View |
| Sep 04, 2024 | Caligan Partners LPEDWARD DAVID JOHNSON | DIRECTOR | -3.44M | $9.51 | $0.00 | SELL | -32.91% | 7.02M | Aug 30 | View |
| Sep 04, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | 1.11K | $9.50 | -$4.32K | SELL-OPTIONS | 0.97% | 115.81K | Aug 30 - Sep 03 | View |
| Sep 04, 2024 | Russell Schundler | GENERAL COUNSEL | 1.63K | $9.50 | -$6.74K | SELL-OPTIONS | 0.33% | 503.12K | Aug 30 - Sep 03 | View |
| Sep 04, 2024 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 1.33K | $9.50 | -$5.19K | SELL-OPTIONS | 0.87% | 154.32K | Aug 30 - Sep 03 | View |
| Sep 04, 2024 | Michael Kaseta | CFO AND COO | 1.26K | $9.50 | -$10.25K | SELL-OPTIONS | 0.40% | 314.97K | Aug 30 - Sep 03 | View |
| Jul 29, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | -1.83K | $11.44 | -$20.97K | SELL | -1.59% | 113.39K | Jul 26 | View |
| Jul 22, 2024 | Rajeev Saggar | CHIEF MEDICAL OFFICER | -1.87K | $11.13 | -$20.85K | SELL | -0.89% | 208.33K | Jul 19 | View |
| Jul 15, 2024 | Roger Jeffs | CHIEF EXECUTIVE OFFICER | -8.05K | $12.53 | -$100.90K | SELL | -0.34% | 2.36M | Jul 12 | View |
| Jul 15, 2024 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | -1.53K | $12.53 | -$19.15K | SELL | -1.00% | 151.68K | Jul 12 | View |
| Jul 15, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | 2.76K | $12.53 | -$14.36K | SELL-OPTIONS | 2.45% | 115.23K | Jul 11 - Jul 12 | View |
| Jul 15, 2024 | Russell Schundler | GENERAL COUNSEL | -1.99K | $12.53 | -$24.87K | SELL | -0.40% | 500.18K | Jul 12 | View |
| Jul 15, 2024 | Rajeev Saggar | CHIEF MEDICAL OFFICER | -1.47K | $12.53 | -$18.42K | SELL | -0.69% | 210.20K | Jul 12 | View |
| Jul 15, 2024 | Michael Kaseta | CFO AND COO | -3.91K | $12.53 | -$48.94K | SELL | -1.23% | 312.39K | Jul 12 | View |
| Jun 04, 2024 | Michael Kaseta | CFO AND COO | 1.25K | $14.55 | -$15.92K | SELL-OPTIONS | 0.40% | 316.30K | May 31 - Jun 03 | View |
| Jun 04, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | 1.11K | $14.55 | -$6.62K | SELL-OPTIONS | 0.99% | 112.47K | May 31 - Jun 03 | View |
| Jun 04, 2024 | Russell Schundler | GENERAL COUNSEL | 1.63K | $14.55 | -$10.33K | SELL-OPTIONS | 0.33% | 502.16K | May 31 - Jun 03 | View |
| Jun 04, 2024 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 1.33K | $14.55 | -$7.94K | SELL-OPTIONS | 0.88% | 153.21K | May 31 - Jun 03 | View |
| Apr 23, 2024 | Rajeev Saggar | CHIEF MEDICAL OFFICER | -1.65K | $13.68 | -$22.56K | SELL | -0.77% | 211.67K | Apr 19 | View |
| Apr 16, 2024 | Russell Schundler | GENERAL COUNSEL | -2.06K | $14.58 | -$30.03K | SELL | -0.41% | 500.53K | Apr 12 | View |
| Apr 16, 2024 | Rajeev Saggar | CHIEF MEDICAL OFFICER | -1.52K | $14.58 | -$22.23K | SELL | -0.71% | 213.32K | Apr 12 | View |
| Apr 16, 2024 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | -1.58K | $14.58 | -$23.11K | SELL | -1.03% | 151.88K | Apr 12 | View |
| Apr 16, 2024 | Michael Kaseta | CFO AND COO | -3.14K | $14.58 | -$45.72K | SELL | -0.99% | 315.05K | Apr 12 | View |
| Apr 16, 2024 | Roger Jeffs | CHIEF EXECUTIVE OFFICER | -8.36K | $14.58 | -$121.89K | SELL | -0.35% | 2.37M | Apr 12 | View |
| Apr 15, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | 2.72K | $14.58 | -$17.34K | SELL-OPTIONS | 2.50% | 111.54K | Apr 11 - Apr 12 | View |
| Mar 19, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | 11.23K | $15.81 | -$73.65K | SELL-OPTIONS | 11.53% | 108.64K | Mar 15 - Mar 18 | View |
| Mar 19, 2024 | Russell Schundler | GENERAL COUNSEL | -6.31K | $15.82 | -$136.89K | SELL | -1.24% | 502.59K | Mar 15 - Mar 18 | View |
| Mar 19, 2024 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | -6.11K | $15.82 | -$96.63K | SELL | -3.83% | 153.47K | Mar 18 | View |
| Mar 19, 2024 | Michael Kaseta | CFO AND COO | -9.82K | $15.82 | -$192.47K | SELL | -2.99% | 318.18K | Mar 15 - Mar 18 | View |
| Mar 19, 2024 | Rajeev Saggar | CHIEF MEDICAL OFFICER | -7.53K | $15.82 | -$119.12K | SELL | -3.39% | 214.85K | Mar 18 | View |
| Mar 19, 2024 | Roger Jeffs | CHIEF EXECUTIVE OFFICER | -28.58K | $15.82 | -$452.18K | SELL | -1.19% | 2.38M | Mar 18 | View |
| Mar 04, 2024 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 1.33K | $14.17 | -$7.74K | SELL-OPTIONS | 0.84% | 159.57K | Feb 29 | View |
| Mar 04, 2024 | Jason Adair | CHIEF BUSINESS OFFICER | 1.11K | $14.17 | -$6.45K | SELL-OPTIONS | 1.15% | 97.41K | Feb 29 | View |
| Dec 20, 2023 | Jason Adair | CHIEF BUSINESS OFFICER | 184.00 | $7.70 | -$592.90 | SELL-OPTIONS | 0.34% | 54.93K | Dec 18 | View |
| Dec 18, 2023 | Rajeev Saggar | CHIEF MEDICAL OFFICER | 14.89K | $7.42 | $110.46K | s | 9.98% | 164.10K | Dec 18 | View |
| Dec 18, 2023 | Roger Jeffs | CHIEF EXECUTIVE OFFICER | 139.66K | $7.16 | $1.00M | BUY | 6.84% | 2.18M | Dec 14 | View |
| Dec 18, 2023 | Paul B Manning | DIRECTOR | 279.33K | $7.16 | $2.00M | BUY | 58.29% | 758.56K | Dec 14 | View |
| Dec 14, 2023 | Caligan Partners LPEDWARD DAVID JOHNSON | DIRECTOR | 1.12M | $7.16 | $8.00M | BUY | 10.99% | 11.28M | Dec 14 | View |
| Dec 05, 2023 | Robert A Lippe | CHIEF OPERATIONS OFFICER | 1.22K | $7.28 | -$3.62K | SELL-OPTIONS | 0.63% | 193.79K | Nov 30 | View |
| Dec 05, 2023 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 1.33K | $7.28 | -$3.95K | SELL-OPTIONS | 1.26% | 106.74K | Nov 30 | View |
| Dec 05, 2023 | Jason Adair | CHIEF BUSINESS OFFICER | 1.11K | $7.28 | -$3.29K | SELL-OPTIONS | 2.08% | 54.48K | Nov 30 | View |
| Sep 20, 2023 | Jason Adair | CHIEF BUSINESS OFFICER | 185.00 | $6.51 | -$488.25 | SELL-OPTIONS | 0.35% | 53.64K | Sep 19 | View |
| Sep 05, 2023 | Robert A Lippe | CHIEF OPERATIONS OFFICER | 1.21K | $6.88 | -$3.47K | SELL-OPTIONS | 0.63% | 192.57K | Aug 31 | View |
| Sep 05, 2023 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 1.34K | $6.88 | -$3.69K | SELL-OPTIONS | 1.29% | 105.40K | Aug 31 | View |
| Sep 05, 2023 | Jason Adair | CHIEF BUSINESS OFFICER | 1.12K | $6.88 | -$3.06K | SELL-OPTIONS | 2.13% | 53.45K | Aug 31 | View |
| Jun 02, 2023 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 1.22K | $8.08 | -$5.26K | SELL-OPTIONS | 1.21% | 102.27K | May 31 | View |
| Jun 02, 2023 | Robert A Lippe | CHIEF OPERATIONS OFFICER | 1.12K | $8.08 | -$4.82K | SELL-OPTIONS | 0.60% | 189.65K | May 31 | View |
| Mar 02, 2023 | Robert A Lippe | CHIEF OPERATIONS OFFICER | 4.84K | $7.56 | -$15.36K | SELL-OPTIONS | 2.64% | 188.52K | Feb 28 | View |
| Mar 02, 2023 | Scott Moomaw | CHIEF COMMERCIAL OFFICER | 5.33K | $7.56 | -$16.41K | SELL-OPTIONS | 5.57% | 100.98K | Feb 28 | View |
| Sep 14, 2022 | Michael Kaseta | CHIEF FINANCIAL OFFICER | 8.00K | $5.99 | $47.92K | BUY | 26.78% | 37.88K | Sep 13 | View |
| Sep 07, 2022 | Roger Jeffs | CHIEF EXECUTIVE OFFICER | 43.82K | $5.57 | $243.99K | BUY | 2.64% | 1.70M | Sep 06 | View |
| Sep 07, 2022 | Caligan Partners LPEDWARD DAVID JOHNSON | DIRECTOR | 250.00K | $5.62 | $1.41M | BUY | 2.41% | 10.64M | Sep 06 | View |
| Sep 01, 2022 | Scott Moomaw | SVP, COMMERCIAL | 2.16K | $4.90 | $10.59K | BUY | 28.24% | 9.81K | Aug 31 | View |
| Sep 01, 2022 | Robert A Lippe | CHIEF OPERATIONS OFFICER | 1.92K | $4.90 | $9.41K | BUY | 2.00% | 98.03K | Aug 31 | View |
| Sep 01, 2022 | Michael Kaseta | CHIEF FINANCIAL OFFICER | 1.93K | $4.90 | $9.45K | BUY | 6.89% | 29.88K | Aug 31 | View |
| Sep 01, 2022 | Roger Jeffs | CHIEF EXECUTIVE OFFICER | 993.00 | $4.90 | $4.87K | BUY | 0.06% | 1.66M | Aug 31 | View |
| Jun 01, 2022 | Michael Kaseta | CHIEF FINANCIAL OFFICER | 18.70K | $4.01 | $74.94K | BUY | 202.16% | 27.95K | May 31 | View |
| May 26, 2022 | Caligan Partners LPEDWARD DAVID JOHNSON | DIRECTOR | 79.40K | $3.40 | $269.96K | BUY | 0.77% | 10.39M | May 25 | View |
| May 25, 2022 | Robert A Lippe | CHIEF OPERATIONS OFFICER | 29.63K | $3.38 | $100.00K | BUY | 48.52% | 90.69K | May 24 | View |
| May 25, 2022 | Roger Jeffs | CHIEF EXECUTIVE OFFICER | 28.00K | $3.53 | $98.81K | BUY | 20.96% | 161.61K | May 24 | View |
| May 19, 2022 | Caligan Partners LPEDWARD DAVID JOHNSON | DIRECTOR | 221.10K | $5.89 | $1.30M | BUY | 2.19% | 10.31M | May 17 - May 19 | View |
| Apr 19, 2022 | Paul B Manning | DIRECTOR | 392.16K | $5.10 | $2.00M | BUY | 81.83% | 871.39K | Apr 18 | View |
| Apr 18, 2022 | Caligan Partners LPEDWARD DAVID JOHNSON | DIRECTOR | 1.76M | $5.10 | $9.00M | BUY | 21.19% | 10.09M | Apr 18 | View |
| Nov 12, 2021 | Arthur S Kirsch | DIRECTOR | 30.00K | $4.24 | $127.20K | BUY | 1500.00% | 32.00K | Nov 10 | View |
| Nov 10, 2021 | Russell Schundler | GENERAL COUNSEL | 117.91K | $4.21 | $496.83K | BUY | 100.62% | 235.09K | Nov 10 | View |
| May 19, 2021 | Russell Schundler | GENERAL COUNSEL | 97.75K | $2.77 | $270.82K | BUY | ∞ | 14.50K | May 18 | View |
| Apr 15, 2021 | Paul B Manning | DIRECTOR | 198.41K | $2.52 | $500.00K | BUY | 19.48% | 1.22M | Apr 13 | View |
| Apr 15, 2021 | Roger Jeffs | DIRECTOR | 99.21K | $2.52 | $250.00K | BUY | 533.51% | 117.80K | Apr 13 | View |
| Jan 27, 2021 | Eshelman Ventures LLCFREDRIC ESHELMAN | 10% OWNER | -1.76M | $3.12 | -$5.50M | SELL | -38.82% | 2.78M | Jan 26 | View |
| Jan 26, 2021 | Eshelman Ventures LLCFREDRIC ESHELMAN | 10% OWNER | -1.22M | $2.96 | -$3.61M | SELL | -21.17% | 4.54M | Jan 22 - Jan 25 | View |
| Jan 22, 2021 | Eshelman Ventures LLCFREDRIC ESHELMAN | 10% OWNER | -328.25K | $2.96 | -$972.08K | SELL | -5.39% | 5.76M | Jan 21 | View |
| Jan 21, 2021 | Eshelman Ventures LLCFREDRIC ESHELMAN | 10% OWNER | -147.24K | $2.97 | -$436.80K | SELL | -2.36% | 6.09M | Jan 19 - Jan 20 | View |
| Jan 19, 2021 | Eshelman Ventures LLCFREDRIC ESHELMAN | 10% OWNER | -27.00K | $3.01 | -$81.25K | SELL | -0.43% | 6.23M | Jan 15 | View |
| Jan 15, 2021 | Eshelman Ventures LLCFREDRIC ESHELMAN | 10% OWNER | -37.86K | $3.02 | -$114.33K | SELL | -0.60% | 6.26M | Jan 13 - Jan 14 | View |
| Jan 13, 2021 | Eshelman Ventures LLCFREDRIC ESHELMAN | 10% OWNER | -112.86K | $3.06 | -$345.65K | SELL | -1.76% | 6.30M | Jan 11 - Jan 12 | View |
| Jan 11, 2021 | Eshelman Ventures LLCFREDRIC ESHELMAN | 10% OWNER | -214.72K | $3.11 | -$667.15K | SELL | -3.24% | 6.41M | Jan 07 - Jan 08 | View |
| Dec 28, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | -7.95K | $3.14 | -$24.96K | SELL | -0.12% | 6.63M | Dec 22 | View |
| Dec 22, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | -105.22K | $3.14 | -$329.94K | SELL | -1.56% | 6.63M | Dec 18 - Dec 21 | View |
| Dec 16, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | -6.42K | $3.13 | -$20.09K | SELL | -0.10% | 6.74M | Dec 14 | View |
| Dec 01, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | -400.00 | $3.13 | -$1.25K | SELL | -0.01% | 6.75M | Nov 27 - Nov 30 | View |
| Dec 01, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | -464.18K | $3.17 | -$1.47M | SELL | -6.44% | 6.75M | Nov 19 - Nov 25 | View |
| Nov 27, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | -17.36K | $3.13 | -$54.35K | SELL | -0.26% | 6.75M | Nov 25 | View |
| Nov 25, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | -283.46K | $3.15 | -$894.25K | SELL | -4.02% | 6.76M | Nov 24 | View |
| Nov 24, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | -133.35K | $3.16 | -$421.35K | SELL | -1.86% | 7.05M | Nov 23 | View |
| Jul 02, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | 1.88M | $8.00 | $15.00M | PURCHASE | 35.14% | 7.21M | Jul 02 | View |
| Apr 07, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | 79.25K | $5.09 | $403.45K | PURCHASE | 1.51% | 5.34M | Apr 03 - Apr 06 | View |
| Apr 03, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | 52.22K | $4.90 | $255.91K | PURCHASE | 1.00% | 5.26M | Apr 01 - Apr 02 | View |
| Apr 01, 2020 | Eshelman Ventures LLCFREDRIC ESHELMAN | — | 44.10K | $4.83 | $213.22K | PURCHASE | 0.85% | 5.20M | Mar 30 - Mar 31 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.